Sponsor pipeline

Rapport Therapeutics Inc. clinical trial pipeline

Get alerts when Rapport Therapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
2
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07594119 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal… Focal Seizure Recruiting 2026-10-15
NCT07563881 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal… Focal Seizure Recruiting 2026-10-08
Phase 2
NCT07219407 A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset… Focal Epilepsy Recruiting 2026-01-23
NCT07046494 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I… Bipolar 1 Disorder Active, Not Recruiting 2026-08-10

Disease areas by active trials

Get alerts when Rapport Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free